1. Home
  2. ACCO vs RLMD Comparison

ACCO vs RLMD Comparison

Compare ACCO & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acco Brands Corporation

ACCO

Acco Brands Corporation

HOLD

Current Price

$2.99

Market Cap

272.3M

ML Signal

HOLD

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$7.22

Market Cap

319.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACCO
RLMD
Founded
1893
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Publishing
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
272.3M
319.7M
IPO Year
2005
2012

Fundamental Metrics

Financial Performance
Metric
ACCO
RLMD
Price
$2.99
$7.22
Analyst Decision
Buy
Strong Buy
Analyst Count
1
5
Target Price
$5.00
$12.40
AVG Volume (30 Days)
1.5M
1.3M
Earning Date
04-30-2026
05-11-2026
Dividend Yield
10.35%
N/A
EPS Growth
141.51
45.28
EPS
0.44
N/A
Revenue
$1,524,700,000.00
$13,070.00
Revenue This Year
$3.10
N/A
Revenue Next Year
$0.89
N/A
P/E Ratio
$6.59
N/A
Revenue Growth
N/A
154.83
52 Week Low
$2.81
$0.27
52 Week High
$4.30
$7.65

Technical Indicators

Market Signals
Indicator
ACCO
RLMD
Relative Strength Index (RSI) 38.56 63.70
Support Level $2.84 $3.49
Resistance Level $3.03 $7.41
Average True Range (ATR) 0.10 0.44
MACD 0.03 0.02
Stochastic Oscillator 79.44 72.12

Price Performance

Historical Comparison
ACCO
RLMD

About ACCO Acco Brands Corporation

ACCO Brands Corp is a consumer, technology and business branded products company providing brands and product solutions used in schools, homes and at work. Its brands include At-A-Glance, Barrilito, Buro, Esselte, Five Star, Foroni, GBC, Hilroy, Kensington, Leitz, Mead, PowerA, Quartet, Rapid, Swingline and Tilibra. The Company's product categories include gaming and computer accessories, storage and organization, notebooks, shredding, laminating and binding machines, dry erase boards and do-it-yourself tools. The Company operates through two segments, Americas and International. Americas includes the U.S., Canada, Brazil, Mexico and Chile, and International includes EMEA, Australia, New Zealand and Asia. Its products are sold in the U.S., Europe, Australia, Canada, Brazil and Mexico.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its key product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.

Share on Social Networks: